cas 4472-44-0|| where to buy 2-Chloro-4,6-dimethylpyrimidine

Nombre del producto:2-Chloro-4,6-dimethylpyrimidine

IUPAC Name:2-chloro-4,6-dimethylpyrimidine

Unidad de embalaje	Stock disponible	Precio($)
CM121158-100g	in stock	źȀǯ
CM121158-500g	in stock	ǕƄƞ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 4472-44-0 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :4472-44-0; Fórmula molecular:C6H7ClN2; Punto de fusión:-; Código de sonrisas:CC1=CC(C)=NC(Cl)=N1; Densidad:

: Número de catálogo:CM121158; Peso molecular:142.59; Punto de ebullición:216°C at 760 mmHg; Nº Mdl:MFCD00023199; Almacenamiento:Keep in dark place, inert atmosphere, store at 2-8°C.

: Pyrimidines; Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.

: Seltorexant; Johnson & Johnson pivotal study of Seltorexant shows statistically significant and clinically meaningful improvement in depressive symptoms and sleep disturbance outcomes. Seltorexant meets all primary and secondary endpoints in the pivotal Phase 3 MDD3001 clinical trial of adult and elderly patients with major depressive disorder (MDD) with insomnia symptoms.
Orexin signaling pathways are found to be associated with depression and anxiety. Orexin neurons receive and transmit signals throughout the central nervous system (CNS) that are modulated by their specific receptors (OX1R, OX2R). Seltorexant is an investigational first-in-class selective antagonist of ORX2 receptor. It is developed as an adjunctive therapy for MDD and for the treatment of insomnia disorder.